Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.
This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.Professor Ian Shott, executive chair
Business funding insights
How to grow your company through acquisition
Gurinder Sunner, head of BGF in the Midlands considers ‘How to grow your company through acquisition’ In its simplest form,…
Infrastructure spending is only one part of the solution
The chancellor is right to back an investment-led recovery, but infrastructure is only part of the solution. Business funding is needed too.